Attributing to several benefits of pharmaceutical plastic packaging the overall attractiveness of the market is expected to remain high during the forecast period. By registering a CAGR of 5.8% the overall valuation of the global pharmaceutical packaging market is anticipated to reach US$ 96,339.16 million by 2033.
Increasing pressure to dispatch novel and sensitive medicines, especially those having less shelf life is pushing demand for active packaging solutions. Technological advancements in drug packaging along with supply chain and inventory tracking play a vital role in safe drug delivery from the lab to the market.
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12419
During the pandemic, pharmaceutical and packaging industries faced challenges in the supply chain and the need to change the packaging. Limitations on transportation were creating insufficiency of the raw material and other resources, straining the pharmaceutical plastic packaging solution production processes.
In the first quarter of 2021, the pharmaceutical plastic packaging market did recover at a rapid pace, as various nations resumed their manufacturing activities. They also started taking initiatives for reforming regulations and allowing plastic packaging of drugs for quick distribution of medicines and eliminating Covid-19.
Key Takeaways from the Pharmaceutical Plastic Packaging Market Study Report
- The United States pharmaceutical plastic packaging market is expected to witness consistent growth of 3.6% in the forecast period, owing to rising demand after the pandemic.
- East Asia has emerged as the most lucrative market for pharmaceutical plastic packaging and is expected to create an incremental opportunity of nearly US$ 12 billion by 2030.
- Among the different types of products, plastic bottles rule the roost by contributing 40% market share, followed by caps & closures.
- Primary packaging witnesses the highest demand as it comes in direct contact with the drug. Secondary and tertiary packaging implies the packaging of different groups of primary packaging.
- The next generation of prefilled syringes and cartridges is expected to outbid demand for expensive intravenous infusions (IV infusions) during the forecast period. Such advancements may lead to significant momentum in the production and sales of pharmaceutical plastic packaging going forward.
- Also, Zip-lock bags and pouches are gaining significant traction in the global market as it requires skill to slide a zipper and access the content. Further, the flap provided on the zipper covers it completely when the bag is not in use making it higher in demand these days. It could be quite lucrative for drug packaging solution providers to increase their production capacity and market position in the coming days.
Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-12419
Competitive Landscape for the Pharmaceutical Plastic Packaging Market Players
Gerresheimer AG, SCHOTT AG, Alpha Packaging Holdings Inc., Klöckner Pentaplast Group, Amcor Plc., Berry Global, Inc., Becton, Dickinson and Company, Parekhplast India Ltd, West Pharmaceutical Services, Inc., Wipak Group, Mondi Plc., Sealed Air Corporation, and Constantia Flexibles Group GmbH among others are some key players in the global pharmaceutical plastic packaging market.
In January 2020, Gerresheimer AG expanded its production capacities in plants based out of China and India for manufacturing pharmaceutical plastic packaging. Besides, in April 2020, Gerresheimer Group company Centor Inc., a plastic packaging manufacturer, expanded storage capacity. It also introduced a pre-fillable polymer syringe at a Germany-based plant.
Recent Developments by the Pharmaceutical Plastic Packaging Industries
Increasing demand for child-resistant packaging among consumers is one of the factors driving the pharmaceutical plastic packaging market during the forecast period. Pharmaceutical plastic bottles and containers with an added layer of security are provided with an advanced design to make them child-resistant. As per the United States FDA, pharmaceutical plastic packaging manufacturers have to highlight ‘child-resistant packaging’ on the product label for appraising the consumer.
Ask an Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12419
Key Segments Covered
By Product:
- Plastic Bottles
- Caps & Closures
- Pre-fillable Inhalers
- Pre-fillable Syringes
- Ampoules & Vials
- Blister Packs
- Bags & Pouches
- Jars & Canisters
- Cartridges
- Other Products
By Material Type
- Polyethylene (PE)
- Polypropylene (PP)
- Polyethylene Terephthalate (PET)
- Polyvinyl Chloride (PVC)
- Polyamide (PA)
- Cyclo-olefin Polymer (COP)
- Cyclo-olefin Copolymer (COC)
- Other Materials
By Packaging Type:
- Flexible Packaging
- Rigid Packaging
By Drug Delivery Mode:
- Oral Drug Delivery Packaging
- Injectable Packaging
- Topical Drug Delivery Packaging
- Pulmonary Drug Delivery Packaging
- Transdermal Drug Delivery Packaging
- Ocular Drug Delivery Packaging
- Nasal Drug Delivery Packaging
- Other Drug Delivery Packaging
